Virginia Risperdal and Invega Injury Lawyers
Risperdal and Invega Injury Claims
Defective prescription drugs can lead to product liability lawsuits when they cause injuries and illnesses in consumers. Lawsuits brought over the antipsychotic drugs, Risperdal and Invega, claim the drugs have been linked to debilitating breast growth in young men. These cases of a psychological medication linked to bad physical and emotional injuries to children and young adults have made juries mad when the full tale has been told of corporate greed and hiding information.
What are Risperdal and Invega?
Risperdal (risperidone) and Invega (paliperidone) are strong second-generation antipsychotics manufactured by Johnson & Johnson and approved for the treatment of schizophrenia in adults and adolescents. Risperdal is additionally approved to treat bipolar disorder in adults and adolescents, as well as autism spectrum disorders in children and adolescents. Invega is also approved to treat schizoaffective disorder.
These drugs have a secondary use “off label” to treat attention deficit hyperactivity disorder (ADHD), anxiety, sleep difficulties and depression.
Risperdal has been used for more than 20 years. It was first approved by the Food and Drug Administration (FDA) to treat schizophrenia in 1993, while Invega was approved in 2006. The FDA later expanded their approved uses.
The active ingredient in Risperdal is risperidone, a substance that works by affecting the levels of dopamine and serotonin in the brain. These neurotransmitters are known to affect mood and behavior. Invega, is made with an active ingredient that is a metabolite of risperidone.
What Are The Side Effects of Taking Risperdal or Invega?
Recently research has found increasing numbers of men and boys who suffer from gynecomastia have been taking Risperdal. If you or a loved one took Risperdal, you may be eligible to join a lawsuit if you suffered any of the following:
- Male breast growth
- Liposuction, mastectomy or other surgical procedures to remove excess breast tissue
Johnson & Johnson is Fined over the Marketing of Risperdal and Invega
Recently, Johnson & Johnson was accused of illegally marketing Risperdal and Invega. In 2013, the Department of Justice revealed Johnson & Johnson had agreed to pay $2.2 billion to resolve criminal and civil liability arising from allegations relating to Risperdal, Invega and Natrecor. The pharmaceutical giant was accused of including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to doctors and to the nation’s largest long-term care pharmacy provider. According to an ex-Johnson & Johnson sales manager, the company didn’t even wait to obtain FDA approval before promoting its use for children.
As early as 2003 Johnson & Johnson was said to be training salespeople to promote Risperdal to children’s doctors despite lacking FDA approval at the times.
It was also accused of paying doctors to speak favorably of the drug, sponsoring golf outings and offering other attractive incentives encouraging doctors to prescribe Risperdal to children and adolescents.
These illegal marketing activities landed Johnson & Johnson in trouble with regulators in 36 states.
The Kentucky attorney general announced a lawsuit alleging Johnson & Johnson hid the dangerous side effects of Risperdal and Invega, including diabetes, substantial weight gain, stroke and gynecomastia.
Johnson & Johnson reached an agreement with a number of states to settle the claims of misconduct for $181 million. The companies settled with Texas for $159 million in 2012.
What is the Progress of Lawsuits and Claims over Risperdal and Invega?
Hundreds of lawsuits were filed on behalf of young boys and men in several states. Risperdal has already led to lawsuits from people who said it cause diabetes, prompting New Jersey to centralize Risperdal diabetes cases under mass tort procedures. The number of claims is continuing to rise.
Risperdal gynecomastia cases are presently at various stages of the litigation process and some trials have been held.
In September 2012, Johnson & Johnson settled a single case for an undisclosed amount on the first day of trial in a Pennsylvania state court. The following month, it settled five more cases in Philadelphia. No information on the amount of money these cases were settled for has been disclosed. Big drug makers often try to keep the settlements secret by entering confidentiality agreements with the patients harmed and asking the courts to seal the records that divulge the companies’ bad conduct and knowledge of dangers to the public.
Contact an Experienced Risperdal Attorney
The drug companies continue to push their pills despite the overwhelming evidence of the harm they can do. Cooper Hurley Injury Lawyers has helped many people who have been harmed by dangerous drugs, giving personal service to those even in class action cases. We will provide you with experienced representation and make sure your claim is properly handled among the others in the mass tort litigation. Time may be running out to make your claim although children’s claims may have extended deadlines during the time before they turn 18. Call us at 757.455.0077 or toll free at for a free consultation.